| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Francois Cedric is a Chief Executive Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $19.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | APLS Apellis Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 35,637 | $40.66 | $1,449,122.33 | -1.7% | |
| Jan 15, 2020 | APLS Apellis Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 35,638 | $42.11 | $1,500,787.50 | -1.2% | |
| Dec 16, 2019 | APLS Apellis Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 5,000 | $27.95 | $139,750.00 | -0.5% | |
| Nov 15, 2019 | APLS Apellis Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 5,000 | $27.28 | $136,405.00 | -0.5% | |
| Oct 15, 2019 | APLS Apellis Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 5,000 | $26.31 | $131,550.62 | -0.2% | |
| Sep 16, 2019 | APLS Apellis Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 5,000 | $26.59 | $132,949.12 | -0.2% | |
| Aug 15, 2019 | APLS Apellis Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 10,000 | $26.80 | $268,007.22 | -0.5% |